TY  - JOUR
AU  - Fernandez-Montes, Ana
AU  - Gravalos, Cristina
AU  - Pericay, Carles
AU  - Safont, Ma Jose
AU  - Benavides, Manuel
AU  - Elez, Elena
AU  - Garcia-Alfonso, Pilar
AU  - Garcia-Paredes, Beatriz
AU  - Carrato, Alfredo
AU  - Aranda, Enrique
PY  - 2020
DO  - 10.1016/j.clcc.2020.04.003
UR  - http://hdl.handle.net/10668/15695
T2  - Clinical colorectal cancer
AB  - Colorectal cancer (CRC) is a public health problem: it is the third most common cancer in men (746,000 new cases/year) and the second in women (614,000 new cases/year), representing the second leading cause of death by cancer worldwide. The survival...
LA  - en
PB  - Elsevier
KW  - Biomarkers
KW  - Colorectal neoplasms
KW  - Mutations
KW  - Refractory
KW  - Therapy
KW  - Antineoplastic combined chemotherapy protocols
KW  - Biomarkers, tumor
KW  - Clinical decision-making
KW  - Clinical trials as topic
KW  - Colorectal neoplasms
KW  - Drug resistance, neoplasm
KW  - Expert testimony
KW  - Humans
KW  - Microsatellite instability
KW  - Patient selection
KW  - Practice guidelines as topic
KW  - Progression-free survival
KW  - Spain
TI  - Current Options for Third-line and Beyond Treatment of Metastatic Colorectal Cancer. Spanish TTD Group Expert Opinion.
TY  - research article
VL  - 19
ER  -